For the Inventor, By the Inventor

Enter assignee name

Frankfurt am Main, Germany

Merz+co. Gmbh & Co.

USPTO Granted Patents = 23

Trademarks = 5

Forward Citations = 531

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Werner E Muller (6 out of 7 patents)

Markus R Gold (5 out of 9 patents)

Klaus W Hummel (4 out of 6 patents)

4. Wojciech Danysz (3 out of 14 patents)

5. Ivars Kalvinsh (3 out of 24 patents)

6. Christopher Graham Parsons (3 out of 3 patents)

7. Wolfgang Schatton (3 out of 3 patents)

8. Arthur Scherm (3 out of 11 patents)

9. Eberhard Nurnberg (3 out of 4 patents)

10. Rolf Dieter Beutler (3 out of 4 patents)

11. Aigars Jirgensons (2 out of 13 patents)

12. Erhard Seiller (2 out of 4 patents)

13. Valerjans Kauss (2 out of 12 patents)

14. Rudolf K Zahn (2 out of 3 patents)

15. Eckart Eich (2 out of 2 patents)

23 patents: Sort by Forward Citations

1. 6197338 - Effervescent bath tablet, method of preparing it, and the use thereof (2001-03-06),

2. 6071966 - 1-amino-alkylcyclohexane NMDA receptor antagonists (2000-06-06),

3. 6034134 - 1-Amino-alkylcyclohexane NMDA receptor antagonists (2000-03-07),

4. 5776935 - Pyrido-phtalazin diones and their use against neurological disorders (1998-07-07),

5. 5766628 - Bath and shower composition having vesicle-forming properties and method (1998-06-16),

6. 5498420 - Stable small particle liposome preparations, their production and use in (1996-03-12),

7. 5382601 - Memantine-containing solid pharmaceutical dosage forms having an (1995-01-17),

8. 5288501 - Mechanically-stable, readily-disintegratable tablets made of small (1994-02-22),

9. 5262162 - Cerebral-activating extract (1993-11-16),

10. 5254549 - New BHT ether compounds and their use as hypolipidemic and (1993-10-19),

11. 5180748 - Avarone and its pharmaceutical compositions and use as an antiviral agent (1993-01-19),

12. 5061703 - Adamantane derivatives in the prevention and treatment of cerebral (1991-10-29),

13. 5026732 - Use of avarone for the control of AIDS and ARC (1991-06-25),

14. 5001162 - Use of avarone for the control of adult T-cell leukemia/lymphoma (1991-03-19),

15. 4981869 - Xanthates as antitumor agents (1991-01-01),

Merz+Co. GmbH & Co. is a global healthcare company specializing in aesthetics, neurosciences, and consumer health. With a history dating back to 1908, they have a strong track record of developing innovative and high-quality products that improve patient outcomes. In addition to their pharmaceuticals and medical devices, Merz+Co. is also known for their commitment to sustainability and social responsibility.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

23 Patents

#33 in Frankfurt am Main

#1,998 in Germany

#26,790 in the World

Frankfurt am Main, Germany

Merz+co. Gmbh & Co.

Forward Citations = 531

46 inventors:

Werner E Muller (6 out of 7 patents)

Markus R Gold (5 out of 9 patents)

Klaus W Hummel (4 out of 6 patents)

4. Wojciech Danysz (3 out of 14 patents)

5. Ivars Kalvinsh (3 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…